0000950142-21-003505.txt : 20211102
0000950142-21-003505.hdr.sgml : 20211102
20211102160627
ACCESSION NUMBER: 0000950142-21-003505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210716
FILED AS OF DATE: 20211102
DATE AS OF CHANGE: 20211102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Javitt Daniel C.
CENTRAL INDEX KEY: 0001864534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 211371252
MAIL ADDRESS:
STREET 1: 1201 NORTH MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 N. MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 N. MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
es210197024_4-javittd.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-16
0
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001864534
Javitt Daniel C.
C/O NRX PHARMACEUTICALS, INC.
1201 NORTH MARKET STREET, SUITE 111
WILMINGTON
DE
19801
0
0
1
0
Common Stock
2021-07-16
4
G
0
434594
D
13537270
I
By Glytech LLC
Common Stock
2021-07-16
4
G
0
434594
D
13102676
I
By Glytech LLC
Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers.
Held by Glytech, LLC of which the Reporting Person is the sole owner.
/s/ Daniel Javitt
2021-11-02